Preventing or delaying the onset of end-stage kidney disease is vital. By implementing a results-driven, value-based approach, Dallas Nephrology Associates has demonstrated improved patient outcomes and value for payers.
LeAnn Phelps, MSN
Advertisement
Articles by LeAnn Phelps, MSN
Advertisement
Latest Updated Articles
Dallas Nephrology Associates’ Journey to Value-Based CareDecember 10th 2024
Advertisement
Advertisement
Trending on AJMC
1
Hybrid, Outpatient, Network-Based: Bispecific Programs Take Shape Differently
2
Chemo-Free Options Abound for Transplant-Ineligible MCL, Kumar Explains
3
Study Finds Flaw in Method for Key Oncology Value-Based Care Model
4
Aficamten Outperforms Metoprolol Across All Phases of Exercise in Obstructive HCM
5